Evidence map›Paper›PMID 34641457›Full record

ReviewMolecules (Basel, Switzerland)2021

Pharmacological and Therapeutic Potential of Myristicin: A Literature Review.

Elisa Frederico Seneme, Daiane Carla Dos Santos, Evelyn Marcela Rodrigues Silva, Yollanda Edwirges Moreira Franco, Giovanna Barbarini Longato

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 87 citations in OpenAlex.

  1. RSC advances · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Myristicin fromAntibiotics (Basel, Switzerland) · 2026
    Article
  7. Multi-stage insecticide potentials ofCurrent research in parasitology & vector-borne diseases · 2026
    Article
  8. Dual action of herbal compounds inFrontiers in immunology · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Insight into Romanian Wild-GrownAntibiotics (Basel, Switzerland) · 2024
    Article
  16. Veterinary world · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elisa Frederico SenemeResearch Laboratory in Molecular Pharmacology of Bioactive Compounds, São Francisco University (USF), Bragança Paulista 12916900, SP, Brazil.
Daiane Carla Dos SantosResearch Laboratory in Molecular Pharmacology of Bioactive Compounds, São Francisco University (USF), Bragança Paulista 12916900, SP, Brazil.
Evelyn Marcela Rodrigues SilvaResearch Laboratory in Molecular Pharmacology of Bioactive Compounds, São Francisco University (USF), Bragança Paulista 12916900, SP, Brazil.
Yollanda Edwirges Moreira FrancoGraduate Program in Health Science, São Francisco University, Bragança Paulista 12916900, SP, Brazil.
Giovanna Barbarini LongatoResearch Laboratory in Molecular Pharmacology of Bioactive Compounds, São Francisco University (USF), Bragança Paulista 12916900, SP, Brazil.ORCID 0000-0001-5828-8957
Universidade São Francisco · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products have been used by humanity for many centuries to treat various illnesses and with the advancement of technology, it became possible to isolate the substances responsible for the beneficial effects of these products, as well as to understand their mechanisms. In this context, myristicin, a substance of natural origin, has shown several promising activities in a large number of in vitro and in vivo studies carried out. This molecule is found in plants such as nutmeg, parsley, carrots, peppers, and several species endemic to the Asian continent. The purpose of this review article is to discuss data published in the last 10 years at Pubmed, Lilacs and Scielo databases, reporting beneficial effects, toxicity and promising data of myristicin for its future use in medicine. From 94 articles found in the literature, 68 were included. Exclusion criteria took into account articles whose tested extracts did not have myristicin as one of the major compounds.

Indexed as

Allylbenzene DerivativesAnimalsDioxolanesHumansMyristicaProtective AgentsReview Literature as TopicAllylbenzene DerivativesDioxolanesmyristicinProtective Agentsbioactive compoundsmyristicinnatural productsnutmegtherapeutic properties

Identifiers

PMID34641457
PMCPMC8512857
OpenAlexW3204319669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.